SE7605927L - Sett att framstella en unik kristallinisk polymorf form av flunisolind och dess anvendning for behandling av respirationssjukdomar - Google Patents

Sett att framstella en unik kristallinisk polymorf form av flunisolind och dess anvendning for behandling av respirationssjukdomar

Info

Publication number
SE7605927L
SE7605927L SE7605927A SE7605927A SE7605927L SE 7605927 L SE7605927 L SE 7605927L SE 7605927 A SE7605927 A SE 7605927A SE 7605927 A SE7605927 A SE 7605927A SE 7605927 L SE7605927 L SE 7605927L
Authority
SE
Sweden
Prior art keywords
fluorisolide
polymorphic form
solvent
treatment
alpha
Prior art date
Application number
SE7605927A
Other languages
Unknown language ( )
English (en)
Other versions
SE421426B (sv
Inventor
J H Fried
R E Jones
G T Haringer
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of SE7605927L publication Critical patent/SE7605927L/sv
Publication of SE421426B publication Critical patent/SE421426B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7605927A 1975-05-27 1976-05-25 Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion SE421426B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130175A 1975-05-27 1975-05-27
US58130075A 1975-05-27 1975-05-27

Publications (2)

Publication Number Publication Date
SE7605927L true SE7605927L (sv) 1976-11-28
SE421426B SE421426B (sv) 1981-12-21

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7605927A SE421426B (sv) 1975-05-27 1976-05-25 Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion

Country Status (15)

Country Link
JP (1) JPS51144719A (sv)
AT (1) AT357702B (sv)
AU (1) AU506080B2 (sv)
CA (1) CA1075228A (sv)
DE (2) DE2661037C2 (sv)
ES (1) ES448220A1 (sv)
FR (1) FR2361900A1 (sv)
GB (1) GB1525181A (sv)
HK (1) HK8580A (sv)
IL (1) IL49652A (sv)
MX (1) MX3864E (sv)
MY (1) MY8000275A (sv)
NL (1) NL191234C (sv)
NZ (1) NZ180946A (sv)
SE (1) SE421426B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55154997A (en) * 1979-05-21 1980-12-02 Syntex Corp Manufacture of flunisolide having peculiar crystal form
EP0039369B1 (en) * 1980-05-02 1983-06-15 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
KR0132576B1 (ko) * 1988-10-05 1998-04-17 로렌스 티. 웰츠 항-용매 내로의 침전을 통한 미분 고형물 결정 분말의 제조 방법
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable preparations for creating propellant-free sprays
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
EP1273292B1 (en) 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN105188758A (zh) * 2013-03-15 2015-12-23 梅迪奇斯医药公司 氟尼缩松的局部组合物及治疗方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
BE585432A (fr) * 1958-12-08 1960-06-08 American Cyanamid Co Stéroïdes fluorés.
US3282791A (en) 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
FR2038105A1 (fr) 1969-04-01 1971-01-08 Syntex Corp Composition anti-inflammatoire locale et son mode d'utilisation
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (de) 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
CA1075228A (en) 1980-04-08
MY8000275A (en) 1980-12-31
NZ180946A (en) 1978-07-28
HK8580A (en) 1980-03-14
FR2361900B1 (sv) 1979-04-13
SE421426B (sv) 1981-12-21
GB1525181A (en) 1978-09-20
DE2624924C2 (de) 1986-11-27
NL7605699A (nl) 1976-11-30
ES448220A1 (es) 1977-11-01
IL49652A (en) 1979-05-31
AU1430176A (en) 1977-12-01
DE2624924A1 (de) 1977-12-15
NL191234C (nl) 1995-04-03
ATA388376A (de) 1979-12-15
AU506080B2 (en) 1979-12-13
FR2361900A1 (fr) 1978-03-17
JPS6247880B2 (sv) 1987-10-09
DE2661037C2 (sv) 1989-04-06
MX3864E (es) 1981-08-26
IL49652A0 (en) 1976-07-30
AT357702B (de) 1980-07-25
JPS51144719A (en) 1976-12-13
NL191234B (nl) 1994-11-01

Similar Documents

Publication Publication Date Title
SE7605927L (sv) Sett att framstella en unik kristallinisk polymorf form av flunisolind och dess anvendning for behandling av respirationssjukdomar
ES413911A1 (es) Un metodo de convertir un esteroide antiflamatorio que ex- hibe crecimiento cristalino en propulsores de aerosol a una forma que no exhibe dicho crecimiento.
NL7706947A (nl) Werkwijze voor het vervaardigen van koolzuur bevattend snoepgoed, alsmede het product van de werkwijze.
SE7713341L (sv) Sett att framstella grenade och cykloalifatiska estrar ur androstan- och ostranserierna
GB2003889A (en) Process for the recovery of polymers from liquid dispersions thereof
CA1022942A (en) Process for spheroidization of rdx crystals
AU502669B2 (en) Removal of acid gas from process gas
NL7803211A (nl) Werkwijze voor de scheiding van stereoisomere cyclische carbonzuren.
AU537572B2 (en) Production of polyhydroxybutyric acid from methylbacterium organopnilum
DE3061060D1 (en) Process for the production of epsilon-caprolactone from cyclohexanone and perpropionic acid
IT1165252B (it) Procedimento di purificazione dell'acido ursodesossicolico attraverso nuovi derivati
IE781438L (en) Tetraline derivatives
UA40574C2 (uk) Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки
ES459294A1 (es) Procedimiento para la preparacion de antraquinon-bis-amidi- nas.
ATA341975A (de) Verfahren zur herstellung von flammwidrigen, harten, urethangruppen aufweisenden schaumstoffen
DD133150A5 (de) Verfahren zur herstellung von mehrfach halogenierten steroiden
IE44763L (en) 3, 5, 5-trimethylhexanoyl ferrocene.
IE780767L (en) Peptide complexes of desoxyribonucleic acid.
ES478530A1 (es) Procedimiento para la preparacion de nuevos compuestos ana- logos de prostaciclina.
HUP0004916A2 (hu) Eljárás 1,2,3,4-tetrahidroizokinolin-2,3-dikarbonsavanhidrid és felhasználásával (S)-N-terc-butil-1,2,3,4-tetrahidroizokinolin-3-karboxamid előállítására
US3779880A (en) Process for preparing thietane derivatives
US2990415A (en) 9-substituted delta4-androstenes
SU623848A1 (ru) Сульфоксин 6- -/гексагидро-1н-азепин-1-ил/метиленамино/пенициллановой кислоты как промежуточный продукт дл получени - -/гексагидро-1н-азопин-1-ил/метиленамино/ цефалоспорановой кислоты или ее модификации
ES466909A1 (es) Procedimiento quimico para la sintesis industrial del cloro-formiato y del tiocloroformiato de vinilo y de isopropenilo.
EP0180754A3 (de) 3,4-Diazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7605927-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7605927-8

Format of ref document f/p: F